TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 52 filers reported holding TARSUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $364,710 | +54.3% | 20,552 | +57.1% | 0.00% | – |
| Q2 2023 | $236,374 | +156.0% | 13,081 | +78.1% | 0.00% | – |
| Q1 2023 | $92,327 | -8.8% | 7,345 | +6.4% | 0.00% | – |
| Q4 2022 | $101,198 | +146.8% | 6,903 | +182.9% | 0.00% | – |
| Q3 2022 | $41,000 | +86.4% | 2,440 | +59.4% | 0.00% | – |
| Q2 2022 | $22,000 | +46.7% | 1,531 | +76.4% | 0.00% | – |
| Q1 2022 | $15,000 | -21.1% | 868 | +6.1% | 0.00% | – |
| Q4 2021 | $19,000 | +5.6% | 818 | 0.0% | 0.00% | – |
| Q3 2021 | $18,000 | -25.0% | 818 | 0.0% | 0.00% | – |
| Q2 2021 | $24,000 | +14.3% | 818 | +28.0% | 0.00% | – |
| Q1 2021 | $21,000 | -22.2% | 639 | 0.0% | 0.00% | – |
| Q4 2020 | $27,000 | – | 639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,779,158 | $32,149,385 | 4.73% |
| COWEN AND COMPANY, LLC | 1,999,383 | $36,128,850 | 3.00% |
| Vivo Capital, LLC | 2,262,200 | $40,877,954 | 2.82% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $32,300,613 | 1.93% |
| Cormorant Asset Management, LP | 1,421,422 | $25,685,096 | 1.44% |
| Sands Capital Ventures, LLC | 260,000 | $4,698,200 | 1.39% |
| Ghost Tree Capital, LLC | 150,000 | $2,710,500 | 0.90% |
| RTW INVESTMENTS, LP | 2,548,125 | $46,044,619 | 0.88% |
| Perceptive Advisors | 1,296,416 | $23,426,237 | 0.68% |
| TFG Asset Management GP Ltd | 165,000 | $2,981,550 | 0.40% |